AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

14 May
AHFS Drug Information logo
AHFS May 2019 Update

This update contains 3 new monographs, 31 revised monographs and 1 new MedWatch alerts.

New monographs: Triclabendazole, Esketamine Hydrochloride, Cetirizine Hydrochloride

Revised monographs: Fondaparinux, Palonosetron, OnabotulinumtoxinA, guanFACINE, Tofacitinib, Mechlorethamine, AbobotulinumtoxinA, IncobotulinumtoxinA, RimabotulinumtoxinB, Mepolizumab, Netupitant/Palonosetron, Obeticholic Acid, Netarsudil, Ibalizumab-uiyk, Erenumab-aooe,
Fremanezumab-vfrm, Galcanezumab-gnlm, aMILoride, Methyldopa, Chlorothiazide, Nystatin, Potassium Supplements, Ethacrynic Acid, Felodipine, Fosinopril, Quinapril, Torsemide, Moexipril, Nisoldipine, Trandolapril, Perindopril

New MedWatch alerts on the following monographs: Febuxostat

09 Apr
AHFS Drug Information logo
AHFS April 2019 Update

This update contains 4 new monographs, 30 revised monographs and 1 new MedWatch alerts.

New monographs: Tafenoquine; Rifamycin; Caplacizumab-yhdp; PrabotulinumtoxinA-xvfs

Revised monographs: Paricalcitol; Eprosartan; Telmisartan; Febuxostat; Factor IX (Recombinant), albumin fusion protein; Factor X (Human); Cobicistat; Calcifediol; Trientine; Benralizumab; Tezacaftor and Ivacaftor; Tafenoquine; Sarecycline; cloNIDine; penicillAMINE; Ergocalciferol; Calcitriol; Propranolol; Methylene Blue; Metoprolol; Vitamin D Analogs General Statement; Timolol; Pindolol; Labetalol; Acebutolol; Esmolol; Bisoprolol; Betaxolol; Carvedilol; Doxercalciferol

New MedWatch alerts on the following monographs: Febuxostat

12 Mar
AHFS Drug Information logo
AHFS March 2019 Update

This update contains 4 new monographs, 35 revised monographs, 9 discontinued monographs and 6 new MedWatch alerts.

New monographs: Prucalopride; Ravulizumab-cwvz; Amifampridine; Tagraxofusp-erzs

Revised monographs: Moxifloxacin; Cevimeline; Gemifloxacin; Ambrisentan; Nebivolol; Liraglutide; Pitavastatin; Azilsartan; Canagliflozin; Riociguat; Sofosbuvir; Dapagliflozin; Pembrolizumab; Empagliflozin; Atezolizumab; Delafloxacin; Copanlisib; Pilocarpine; Magnesium Sulfate; Chlorthalidone; metOLazone; Methyclothiazide; hydroCHLOROthiazide; Bendroflumethiazide; Nadolol; Nystatin; Calcium Salts; Indapamide; Ciprofloxacin; ASHP Guidelines on Handling Hazardous Drugs; Ofloxacin; Fosfomycin; Azithromycin; levoFLOXacin; tiaGABine Hydrochloride 

Discontinued monographs: Telithromycin; telbivudine; albiglutide; dasabuvir, ombitasvir, paritaprevir, and ritonavir; ombitasvir, paritaprevir, and ritonavir; erythromycin estolate; insulin zinc; nystatin; ticarcillin and clavulanate 

New MedWatch alerts on the following monographs: moxifloxacin; gemifloxacin; delafloxacin; ciprofloxacin; ofloxacin; levofloxacin

12 Feb
AHFS Drug Information logo
AHFS Drug Information February 2019 update 

This update contains 5 new monographs, 8 revised monographs and 2 discontinued monographs.

New monographs: Cenegermin-bkbj; Emapalumab-lzsg; Larotrectinib; Glasdegib; Gilteritinib

Revised monographs: Pitavastatin; Azilsartan; Mepolizumab; Lutetium Lu 177 Dotatate; Megestrol; chlordiazePOXIDE; Fosfomycin; tiaGABine Hydrochloride

Discontinued monographs: Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir; Ombitasvir, Paritaprevir, and Ritonavir

15 Jan
AHFS Drug Information logo
AHFS Drug Information January 2019 update 

This update contains 6 new monographs and 45 revised monographs. 

New monographs: Inotersen; Moxetumomab Pasudotox-tdfk; Talazoparib; Baloxavir; Revefenacin; Lorlatinib

Revised monographs: Alosetron; Fluticasone; Oxcarbazepine; Candesartan; Olmesartan; Budesonide; Influenza Vaccine Live Intranasal; Dronabinol; Zoster Vaccine Live; Febuxostat; Rufinamide; Influenza Vaccine Recombinant; Macitentan; Patiromer; Zoster Vaccine Recombinant; Netarsudil; Codeine; Sodium Polystyrene Sulfonate; carBAMazepine; Loperamide; Codeine; HYDROcodone; Bupivacaine; Captopril; Amphetamines General Statement; Opiate Agonists General Statement; Thiazides General Statement; Local Anesthetics, Parenteral, General Statement; Insulins General Statement; dilTIAZem; NIFEdipine; Haemophilus b Vaccine; Enalapril; Benazepril; Ramipril; amLODIPine; Lisinopril; lamoTRIgine; Losartan; Influenza Virus Vaccine Inactivated; Meningococcal Groups A, C, Y, and W-135 Vaccine; OLANZapine; Topiramate; Valsartan; Irbesartan

 

11 Dec
AHFS Drug Information logo
AHFS Drug Information December 2018 update 

This update contains 8 new monographs, and 47 revised monographs. 

New monographs: Cannabidiol; Cemiplimab-rwlc; Dacomitinib; Galcanezumab-gnlm; Sarecycline; Duvelisib; Elapegademase-lvlr; Omadacycline

Revised monographs: Gemtuzumab; Formoterol; Zonisamide; Cisatracurium; Bendamustine; Lacosamide; Dolutegravir; Vilanterol; Pembrolizumab; Nivolumab; Ibrutinib; Evolocumab; Lumacaftor and Ivacaftor; Enasidenib; Glecaprevir and Pibrentasvir; DAUNOrubicin and Cytarabine; Inotuzumab; Abemaciclib; Acalabrutinib; Dolutegravir and Rilpivirine; Apalutamide; Tobramycin; Methotrexate; Cytarabine; Gentamicin; DAUNOrubicin; fentaNYL; Baclofen; Pancuronium; Succinylcholine; Dantrolene; vinCRIStine; Neuromuscular Blocking Agents General Statement; Verapamil; Atenolol; Atracurium; Amoxicillin; Penicillin G Benzathine; Penicillin G Potassium, Penicillin G Sodium; Penicillin G Procaine; Vecuronium; cefTRIAXone; Flecainide; Sotalol; Rocuronium; Salmeterol; Antiretroviral Agents General Statement 

View more View all content updates